Search Results for 'arv hiv'

arv hiv published presentations and documents on DocSlides.

Global Price Reporting Mechanism (GPRM); ARV Drug Regulatory Status  Database  (DRS); ARV Active Ph
Global Price Reporting Mechanism (GPRM); ARV Drug Regulatory Status Database (DRS); ARV Active Ph
by luanne-stotts
relevance and options for the future. B. Dongmo N...
ARV Procurement and Value For Money
ARV Procurement and Value For Money
by marina-yarberry
Cameroon Perspectives . IAS, Paris 23 July, . 201...
Eliminating Perinatal HIV Transmission
Eliminating Perinatal HIV Transmission
by jane-oiler
A Curriculum for OB/GYN Resident and Midwifery Pr...
Newborn born  TO hiv ( )
Newborn born TO hiv ( )
by test
mother. ID weekly conferences. Gouri Scheurmann ....
HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines
HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines
by stefany-barnette
Treatment Recommendations for Pregnant and Breast...
“Getting to Zero:  Thailand’s
“Getting to Zero: Thailand’s
by aaron
Experience with E-MTCT”. Petchsri. . Sirinirun...
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
by jade
Madeline Droney, PharmD. In it for the Long-Haul. ...
Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches
Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches
by myesha-ticknor
Clinical aspects of ADRs in HIV and ARV toxicity ...
New Directions in the 2015  Consolidated ARV Guidelines Update
New Directions in the 2015 Consolidated ARV Guidelines Update
by test
Meg . Doherty, MD, PhD, MPH. 19 July 2015. WHO Sa...
Ulwazi   malunga   nokungasebenzi
Ulwazi malunga nokungasebenzi
by marina-yarberry
(. kwamayeza. ) e HIV. Kukuthini. . ukungeva. ?...
Assoc.Prof
Assoc.Prof
by yoshiko-marsland
. . Thanyawee. . Puthanakit. , MD.. Division of ...
Scaling up what works: replicating models on community serv
Scaling up what works: replicating models on community serv
by yoshiko-marsland
Jennifer Gatsi Mallet. Namibia Women’s Health N...
FINANCING ARV
FINANCING ARV
by tatiana-dople
EXPERIENCE FROM MALAYSIA. BY. SHA’ARI NGADIMAN,...
High-dose rifampicin
High-dose rifampicin
by pasty-toler
TB treatment regimen to . reduce . 12-month . mor...
Promoting Adherence and Retention in ARV-based Prevention
Promoting Adherence and Retention in ARV-based Prevention
by briana-ranney
Dr. Seema Sahay, Ph.D. Division of Social and Beh...
Diagnosis and Initial Management of HIV/AIDS:
Diagnosis and Initial Management of HIV/AIDS:
by cheryl-pisano
What the Primary Care Provider Should Know. Carol...
Cancer in HIV Patients in Latin America and the Caribbean:
Cancer in HIV Patients in Latin America and the Caribbean:
by SugarLips
Characteristics in seven sites from the . CCASAnet...
CROI 2019:  ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
 The ART of HIV Management:
The ART of HIV Management:
by briana-ranney
An Antiretroviral Therapy Review. Sarah Pérez, P...
Potential safety issue affecting women living with HIV using
Potential safety issue affecting women living with HIV using
by luanne-stotts
dolutegravir. at the time of conception. Meg Doh...
Perinatal HIV Transmission Prevention
Perinatal HIV Transmission Prevention
by sherrill-nordquist
Missed Opportunities. Ryan White 2012 Conference....
Dr Vincent Habiyambere & Boniface Dongmo Nguimfack
Dr Vincent Habiyambere & Boniface Dongmo Nguimfack
by myesha-ticknor
Strategic Information and Planning (SIP) – WHO ...
Subgroup Efficacy Analyses of
Subgroup Efficacy Analyses of
by eddey
Long-Acting Subcutaneous Lenacapavir in . Heavily ...
New Science, New Hope: Giving Women Power Over
New Science, New Hope: Giving Women Power Over
by joyce
AIDS. The John Kevany Memorial Lecture. Zeda Rosen...
29% abnormal scores   in
29% abnormal scores in
by Thrillseeker
screening for . depression and anxiety. All 26 ado...
New drugs for individuals
New drugs for individuals
by Ziggystardust
with multi-resistant virus. 6 APRIL 2020. Faculty....
CNS  pharmacology   of  antiretroviral
CNS pharmacology of antiretroviral
by PlayfulSpirit
drugs. . and. relevant . interactions. . betwee...
Cases From the Clinic( ians
Cases From the Clinic( ians
by ImNotABaby
):. Antiretroviral Therapy Cases . and . Panel Dis...
ARV Resistance  1 Learning Objectives
ARV Resistance 1 Learning Objectives
by naomi
Define drug resistance. Identify . factors that in...
Kebijakan  Program  Pencegahan
Kebijakan Program Pencegahan
by blondiental
dan . Pengendalian . HIV . AIDS . dan. . PIMS. K...
 New Directions in  the future 2015
New Directions in the future 2015
by mitsue-stanley
Consolidated ARV Guidelines Update. Meg . Doherty...
Non-ARV  Based Interventions to Combat
Non-ARV Based Interventions to Combat
by tatiana-dople
Non-ARV Based Interventions to Combat HIV/AIDS:...
The Kabeho  Study*:  Kigali
The Kabeho Study*: Kigali
by phoebe-click
Antiretroviral and Breastfeeding Assessment for t...
Innovative Strategies for the Management
Innovative Strategies for the Management
by karlyn-bohler
of HIV Infection. Dual therapies without NRTIs. J...
The challenge of maintaining care and support to HIV infect
The challenge of maintaining care and support to HIV infect
by natalia-silvester
Dr Doumbouya Bangaly. 1. Background. . Post elec...
New Prevention Technologies Workshop
New Prevention Technologies Workshop
by karlyn-bohler
Module 1: . Basic definitions. www.icad-cisd.com....
CDC’s Interim Guidance on the Use of PrEP in Heterosexual
CDC’s Interim Guidance on the Use of PrEP in Heterosexual
by calandra-battersby
Adults:. . Implications . for Clinical Practice....
Track B
Track B
by karlyn-bohler
Clinical Science, Treatment and Care. ZIMBABWE ...
Quantitative Adherence Measurement In Infants  Receiving ARV Syrups:
Quantitative Adherence Measurement In Infants Receiving ARV Syrups:
by ellena-manuel
P1115 . Zimbabwe. , Harare Family . Care Experien...
Comprehensive  Guideline Summary
Comprehensive Guideline Summary
by aaron
Guidelines for the Use of Antiretroviral Agents. ...